Tristel - TSTL Share Forecast, Price & News

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand; contamination control products, which include cleanroom, laboratory, pharmaceutical, cosmetic, and toiletry disinfectants under the Crystel brand; and airborne and veterinary device disinfectants under the Anistel brand. The company was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Tristel Price Performance

Tristel stock remained flat at GBX 377.50 ($4.63) during mid-day trading on Friday. The company's stock had a trading volume of 53,715 shares, compared to its average volume of 83,023. The company has a debt-to-equity ratio of 20.83, a current ratio of 5.69 and a quick ratio of 4.46. The business has a fifty day moving average of GBX 352.66 and a two-hundred day moving average of GBX 349.88. Tristel has a 1 year low of GBX 270 ($3.31) and a 1 year high of GBX 810 ($9.93). The company has a market capitalization of £178.27 million and a P/E ratio of 7,550.00.

Tristel Increases Dividend

The business also recently disclosed a dividend, which will be paid on Wednesday, August 10th. Shareholders of record on Thursday, July 28th will be paid a dividend of GBX 3 ($0.04) per share. This is a positive change from Tristel's previous dividend of $2.62. This represents a yield of 0.85%. The ex-dividend date of this dividend is Thursday, July 28th. Tristel's dividend payout ratio is currently 14,000.00%.

Insiders Place Their Bets

In other news, insider Paul Christopher Swinney sold 300,000 shares of the firm's stock in a transaction on Friday, July 22nd. The stock was sold at an average price of GBX 333 ($4.08), for a total value of £999,000 ($1,224,114.69).